FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV)

BY Reuters • October 30, 2023

FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV) vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS/File photo

« Pfizer RSV vaccine lags GSK’s as head-to-head competition underway